BIOCAD started working on mRNA vaccine against coronavirus
Biotechnological company BIOCAD has announced the research in order to create an mRNA vaccine against SARS-COV-2 (coronavirus). Development will be based on previous pipelines for mRNA-oncovaccines creation: an area where the company has a great expertise. The first animal studies are scheduled for the end of April. According to Dmitry Morozov, BIOCAD CEO, today the whole world is working on the search for coronavirus treatment: “By now, 66 companies around the world have announced the development of drugs against SARS-COV-19,…
You might be interested in
